Use access key #2 to skip to page content.
$15.32 -0.73 (-4.55%)
10/7/2008 1:43 PM

Schering-Plough Corp (SGP)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.

View All Commentary (SGP)

Recs

0

Avatar vetsuburb (38.43) Submitted: 3/24/08 10:21 PM : Outperform Start Price: $19.89 SGP Score: 0.59

4 new drugs on market, good cash flow, well financed, price is good lower p/e historically spg is at the mid 30's, the drug controvery is basically in the us and we will see the cardio's behind the drug, insiders owner 13%. This is a good company coming out of a tough bad time

Report this Post Replies: 0 | Reply

Featured Broker Partners